I haven’t posted in a while, so just letting everyone know things are good here.

to those who are focusing on the secondary outcome of self reported time to clinical recovery, remember this is open label. Can’t draw any firm conclusions, as the authors state Also remember EPIC-SR, placebo controlled, did not show a difference in median time to sustained alleviation of symptoms

Breaking into bluesky to say that PANORAMIC data on paxlovid‘s (lack of) efficacy in reducing Covid hospitalizations and death in vaccinated cohort is out The drug’s efficacy in this group was so exaggerated by those who should have known better but had reasons not to www.nejm.org/doi/full/10....

this study made me think of @walidgellad.bsky.social www.cidrap.umn.edu/covid-19/dat...

Remember E. coli outbreak linked to onions in McDonald's Quarter Pounders? FDA inspectors found dozens of violations at supplier, like: - ignoring biofilm/debris buildup - not using handwashing sinks - cleaning chemicals getting on food www.cbsnews.com/news/fda-rep...

Truly, one of the best changes to Medicare in decades. If you need a very expensive medicine (or a lot of medicine) and you are on Medicare you now have a hard cap on spending starting on 1/1. That is awesome.

FDA transfers regulatory oversight of medical maggots and leaches from its device center (the organisms previously regulated as medical devices) to biologics center public-inspection.federalregister.gov/2024-31266.p... More on their clinical applications here pmc.ncbi.nlm.nih.gov/articles/PMC...

Some news ... I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions. hspp.sph.brown.edu

I'm looking for a third paper for a Medicaid managed care-focused panel for ASHE. DM me if interested! Please RT, I'm new to the blue skies...

CP3 Associate Director Dr. Katie Suda is learning from past #drugshortages to help mitigate future ones. take a look at her most recent paper comparing US vs Canada. jamanetwork.com/journals/jam...

When prescription drug costs are subjectively set by conflicted intermediates who profit off higher prices and misaligned incentives, the sticker shock isn’t really a shock at all. www.wsj.com/health/healt... @wsj.com

🆕from @LilyBessette & CP3's @TimAndersonMD - a third of patients eligible for weight loss 💊would have been excluded from their clinical trials. Read more @JAMAInternalMed jamanetwork.com/journals/jam...

Reprising this from my AEI colleague Ben Ippolito on the cost of Medicare coverage for GLP-1s. CMS appears to see writing on wall here: As additional indications are approved, most Medicare recipients will get coverage for other co-morbidities. Also, Semaglutide subject to IRA price controls in 2027

My article in @statnews.bsky.social on GLP-1 compounding: the @fda.gov needs to maintain the integrity of its authorities — and the implementation of the Drug Quality and Security Act (DQSA). www.statnews.com/2024/11/19/f...

I do hope it sticks this time @katiepalmer.bsky.social! Nice comments from @walidgellad.bsky.social and @scottgottliebmd.bsky.social.

ICYMI: Our team previously showed ⬆️prices for indomethacin suppositories. Now, we found wide variation in hospital charges for this drug - charges passed to patients b/c the suppositories are excluded from Medicare Parts B&D. More in JAMA Network Open jamanetwork.com/journals/jam...

Oral naltrexone is one of main medications doctors can turn to for treating alcohol use disorder FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug" www.accessdata.fda.gov/scripts/drug...

I’m not posting much here, but I’d like to point out that it is tweets like this that exaggerate study findings. Stat shouldn’t do this. This study design cannot measure impact of COVID on cognition. Rather it compares cognition in those with and without COVID/symptoms with no baseline measure.

Prospective PhD students: Applications are now open for the #PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)

The Department of Health Policy and Management at Pitt is hiring tenure track faculty in policy and health services research. Apply. French fries on salads. https://cfopitt.taleo.net/careersection/pitt_faculty_external/jobdetail.ftl?job=22000867&tz=GMT-04%3A00&tzname=America%2FNew_York

Re-upping this since the health policy contingent is slowly but steadily growing: BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed. I created a health policy feed here:

Welcome, @bnrome.bsky.social ! Check out the health policy list and instructions for contributing to that feed. You can pin the feed to easily get back to it.

Original Humira’s list price grew so much that its actual price after rebates to Medicaid was zero. (It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807194

ICER's report on sickle cell disease🧪 is out today! Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M #healthpolicy

“Another hospital attempted to charge a patient a facility fee of up to $350 for a telehealth visit because the doctor was on hospital property.” 🙃 #healthpolicy https://www.statnews.com/2023/07/07/hospital-facility-fees-biden-initiative/